Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
Pfizer and Bayer to keep Russia's drug supply afloat
Global corporations have decided to distance themselves from Russia as consumer pressure mounts in the West to condemn its invasion of Ukraine.
Pfizer Inc (PFE.N) and Bayer AG (BAYGn.DE) said on Monday that they would continue to supply humanitarian medicines to Russia while cutting back on non-essential spending in the country.
Global corporations have decided to distance themselves from Russia as consumer pressure mounts in the West to condemn its invasion of Ukraine.
"Halting the delivery of medicines, including cancer or cardiovascular therapies, would result in significant patient suffering and potential loss of life, particularly among children and the elderly," Pfizer explained.